U.S. Stock News

NasdaqGS:XE
NasdaqGS:XEElectrical

X Energy (XE) Gets A Tennessee Grant As Valuation Still Looks Pricey

The latest focus on X-Energy (XE) stems from an $11 million economic development grant awarded to its TRISO-X subsidiary to expand nuclear fuel fabrication and research facilities in Oak Ridge, Tennessee. See our latest analysis for X-Energy. For context, X-Energy’s share price return has been weak in recent months, with the stock down 8.17% over 1 day, 16.69% over 7 days, 36.06% over 30 days and 52.64% year to date at a latest share price of $13.83. This suggests momentum has been fading...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk (NYSE:NVO) Wins EU Approval For Oral And Higher Dose Wegovy

Novo Nordisk (NYSE:NVO) has received European Commission marketing authorization for oral Wegovy for weight management across the EU. The EC also approved higher dose injectable Wegovy, expanding dosing options within the existing injectable franchise. The approvals cover 27 EU countries plus Norway, Iceland, and Liechtenstein, creating broader access to GLP-1 based obesity treatments. Novo Nordisk is a major player in diabetes and obesity care, and Wegovy sits at the center of its obesity...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Stock Looks Fully Priced Despite Strong 3 Year Returns

FormFactor stock has delivered a very strong 3 year return and is still up sharply over the past year, yet the valuation checks currently lean expensive rather than pointing to an obvious bargain. FormFactor has returned 207.5% over the past 3 years, which puts extra focus on whether today’s price still offers a comfortable margin for error. AI driven demand for high bandwidth memory and related chip testing can support optimistic expectations, but recent concerns about overvaluation and...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Does Lucid (LCID) Management’s Bankruptcy Denial Clarify Its Real Operational and Liquidity Challenges?

In recent days, Lucid Group has forcefully denied media reports that it was preparing for bankruptcy or a take‑private deal, stressing that adviser AlixPartners is focused on improving operations rather than planning a court‑supervised restructuring. The controversy has thrown a spotlight on Lucid’s liquidity runway, restructuring efforts, and legal challenges around past disclosure of delivery disruptions, giving investors fresh information about the company’s operational and financial...
NYSE:TKR
NYSE:TKRMachinery

Timken (TKR) Stock Looks Cheap Relative to Fair Value

Timken stock has almost doubled over the past five years, and at around US$137.69 per share the Discounted Cash Flow (DCF) intrinsic value estimate still points to roughly 20.3% upside, even though the broader valuation checks only give the company a low score. Timken has returned about 95.9% over five years, which puts today’s valuation debate in the context of a stock that has already rewarded long term holders. The newly secured US$1.2b unsecured revolving credit facility can support...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal Holdings (PYPL) Could Be 13% Undervalued Following Takeover Interest

PayPal Holdings (PYPL) is back in focus after payments company Stripe and private equity firm Advent International reportedly offered US$60.50 per share to acquire the stock in a deal valued at over US$53b. See our latest analysis for PayPal Holdings. The takeover headlines have triggered a sharp short term rebound in PayPal Holdings, with a 7 day share price return of 25.18% and 30 day share price return of 29.97%. However, the 1 year total shareholder return is still down 22.53% and the 5...
NYSE:VNT
NYSE:VNTElectronic

Vontier (VNT) Could Be 18% Undervalued As Earnings Call Nears

Vontier (VNT) has scheduled a conference call and webcast for August 6, 2026, to review its second quarter 2026 financial results, giving investors fresh information to reassess the stock’s recent performance. See our latest analysis for Vontier. Vontier’s recent momentum has picked up into the upcoming results, with a 1-day share price return of 3.10% and a 7-day share price return of 5.81%. However, the 90-day share price return declined 17.96% and the 1-year total shareholder return...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Latest News In Electric Vehicles - Transforming Battery Tech: Premergy's Strategic Shift and Partnerships

The electric vehicle sector is witnessing considerable advancements as Premergy, a subsidiary of Innovative Holdings Alliance, Inc., announces its transformation into an advanced energy technology company with a focus on battery management. The company's strategic initiatives encompass commercialization efforts across automotive, AI data centers, and drone markets, highlighting the potential for robust battery technologies in these areas. By partnering with Clemson University's International...
NasdaqGS:ODFL
NasdaqGS:ODFLTransportation

Is Old Dominion Freight Line’s (ODFL) Slipping Returns Quietly Rewriting Its Core Profit Narrative?

Recently, analysis of Old Dominion Freight Line’s past two years of results highlighted falling unit sales, earnings per share declining at 8.1% annually, and weakening returns on capital, pointing to pressure on its existing profit centers. This combination of softer volumes, shrinking per-share earnings, and eroding capital returns raises questions about how durable the company’s core profit engines really are. We’ll now examine how concerns over eroding returns on capital could reshape...
NYSE:LAZ
NYSE:LAZCapital Markets

Lazard (LAZ) Updates LCOE Report And Elaia Deal, Is It Still 17% Below Fair Value?

Lazard (LAZ) has drawn fresh attention after publishing its 2026 Levelized Cost of Energy+ report, updating investors on roughly $284.7b in assets under management and confirming the acquisition of Elaia Partners. See our latest analysis for Lazard. Lazard’s recent news has arrived during a weak stretch for the stock, with the share price at $43.47 and share price returns down 12.61% year to date and 11.36% over 90 days, while longer term total shareholder returns over three and five years...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Steel Dynamics (STLD) Stock Could Trade At A Cash Flow Discount Despite A 328% Return

Steel Dynamics has delivered very strong long term returns, with the share price up 328.3% over the past five years, while current valuation checks suggest the stock still trades at a discount to an intrinsic value estimate based on a Discounted Cash Flow (DCF) model. A 328.3% gain over five years points to investors already paying up for Steel Dynamics' execution, so the question is whether today’s price still leaves headroom for future cash flows. The valuation debate hinges on how durable...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Fermi (FRMI) Is Down 19.0% After Director Exit Over Governance And $375M Convertibles Deal - Has The Bull Case Changed?

In recent days, Fermi Inc. disclosed the resignation of director designee Miles Everson, who cited governance concerns including withheld board and committee minutes, alongside the completion of a US$375,000,000 offering of 5.00% senior unsecured convertible notes due July 15, 2031 issued under Rule 144A. Everson’s claim that a US$350,000,000 convertible bond transaction was approved via special committee without full board discussion raises pointed questions about how Fermi is balancing...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

How Q2 Earnings Beat, Buybacks and Softer Guidance At Intuitive Surgical (ISRG) Has Changed Its Investment Story

In the past few days, Intuitive Surgical, Inc. reported second-quarter 2026 results showing revenue of US$2.89 billion and net income of US$818.1 million, with both basic and diluted earnings per share from continuing operations rising year on year. Alongside beating earnings expectations, the company advanced its long-running buyback to 30.34 million shares repurchased and highlighted strong global procedure growth across its da Vinci and Ion platforms despite a Class II recall and softer...
NYSE:QGEN
NYSE:QGENLife Sciences

Is Rising Cyclospora Testing Demand Reframing Qiagen’s Infectious Disease Strategy (QGEN)?

Earlier this month, QIAGEN highlighted how its FDA-cleared QIAstat-Dx Gastrointestinal Panel 2 and broader molecular testing portfolio are being used to detect Cyclospora cayetanensis amid more than 1,600 confirmed U.S. cyclosporiasis cases since May, supporting public health investigations into multiple foodborne outbreaks. The announcement underscores QIAGEN’s role in providing specialized, rapid molecular diagnostics for hard-to-detect pathogens, reinforcing the relevance of its Sample to...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Why Lam Research (LRCX) Is Down 9.1% After AI Capex, Margin, and Export Control Jitters

In recent days, Lam Research has been caught in a broader semiconductor pullback as investors reassess elevated AI-driven capital spending, rising manufacturing costs, and the impact of tighter export controls and geopolitical tensions on equipment demand. Options activity, insider share sales of about US$65.50 million, and concerns over compressed profit margins have amplified worries that higher AI-related investment may not translate into proportionate returns for semiconductor equipment...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Should Strong Earnings Projections and Zacks Rank #1 Status Require Action From Neurocrine Biosciences (NBIX) Investors?

Recently, coverage highlighted that Neurocrine Biosciences, a biopharmaceutical company focused on neurological and psychiatric disorders, is expected to deliver an earnings growth rate of 48.4% this year and currently holds a Zacks Rank #1 (Strong Buy), reflecting very positive analyst sentiment. This combination of projected earnings strength and a top-tier analyst ranking has drawn fresh attention to Neurocrine’s position in neuroscience-focused therapeutics and its potential business...
NYSE:CLH
NYSE:CLHCommercial Services

Clean Harbors (CLH) Names A New Chairman, Is The Stock Fully Priced?

Clean Harbors (CLH) has completed a long signaled leadership transition. Founder Alan S. McKim has retired from the board, and long-time director Robert Willett has stepped in as Chairman. See our latest analysis for Clean Harbors. Clean Harbors shares have gained momentum recently, with a 6.86% 1 month share price return building on a 27.58% year to date move and a 35.71% 1 year total shareholder return. This helps frame this leadership transition against a longer period of strong...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Is Ondas (ONDS) Cheap On Its New Share Sale Overhang?

Ondas (ONDS) recently filed a prospectus supplement that allows existing shareholders, including those who received stock in the Omnisys acquisition, to potentially resell about 3.4 million shares and add fresh supply without new capital for the company. See our latest analysis for Ondas. The prospectus update arrives during a period of pressure on Ondas's share price, which is down 27.8% over the past 30 days and 39.7% year to date, even though the 1 year total shareholder return is 177.1%...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment (AVAV) Stock Looks Cheap On Cash Flow But Expensive On Sales

AeroVironment stock is caught between two valuation messages right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside, while market based multiples paint a more expensive picture. This comes after a share price that is still well below its recent highs despite a 61.3% gain over the past three years. Over the last three years AeroVironment has returned 61.3%, which keeps long term holders ahead even though the stock is currently trading near its...
NYSE:MWA
NYSE:MWAMachinery

How Rising Free Cash Flow and Profitability May Reshape Mueller Water Products’ (MWA) Capital Allocation Choices

In recent years, Mueller Water Products has reported higher operating profits and efficiency, with earnings per share growing faster than revenue as free cash flow margins improved. This shift toward more profitable incremental sales and stronger cash generation suggests the business now has greater flexibility to fund reinvestment, share repurchases, or dividends without stretching its balance sheet. We’ll now examine how this improved free cash flow profile may influence Mueller Water...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock (BLK) Stock Faces Margin Hit As Net Profit Squeeze Challenges Bullish Narratives

BlackRock (BLK) just posted its Q2 2026 numbers, reporting total revenue of US$7.1 billion, basic EPS of US$12.33 and trailing twelve month EPS of US$42.40. Trailing twelve month revenue stands at US$27.3 billion and net income at US$6.6 billion. The company’s revenue has moved from US$24.2 billion on a trailing basis in Q4 2025 to US$27.3 billion in Q2 2026. Over the same period, trailing EPS shifted from US$35.83 to US$42.40. This context helps frame how investors evaluate Q2 profitability...